You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Lipid disorders

Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia

  • Technology appraisal guidance
  • Reference number: TA393
  • Published:  22 June 2016
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Implementation support
  2. Guidance into practice

Tools and resources

Tools and resources to help you put the guidance into practice.

Implementation support

  • NHS England summary of national guidance for lipid management

  • NHS England statin intolerance pathway

  • Measuring the use of NICE guidance

Guidance into practice

  • About the Into practice guide

  • Practical steps to improving the quality of care and services using NICE guidance

Back to top